By Frank Prenesti
Date: Monday 22 Sep 2025
(Sharecast News) - AstraZeneca and Amgen on Monday said their Tezspire drug has been recommended for approval in the European Union for the treatment of adult patients with chronic rhinosinusitis with nasal polyps.
By Michele Maatouk
Date: Tuesday 16 May 2023
(Sharecast News) - Horizon Therapeutics tumbled in pre-market trade on Tuesday following a report that its $27.8bn takeover by Amgen will be challenged by federal regulators.
By Michele Maatouk
Date: Monday 12 Dec 2022
(Sharecast News) - California-based biopharmaceutical group Amgen has agreed to buy Horizon Therapeutics in a $28.3bn deal.
Currency | US Dollars |
Share Price | $ 298.81 |
Change Today | $ 3.00 |
% Change | 1.01 % |
52 Week High | $327.36 |
52 Week Low | $258.59 |
Volume | 1,959,530 |
Shares Issued | 536.90m |
Market Cap | $160,431m |
RiskGrade | 100 |
Strong Buy | 6 |
Buy | 7 |
Neutral | 15 |
Sell | 2 |
Strong Sell | 1 |
Total | 31 |
Time | Volume / Share Price |
15:59 | 100 @ $298.81 |
15:59 | 100 @ $298.81 |
15:59 | 100 @ $298.81 |
15:59 | 100 @ $298.81 |
15:59 | 100 @ $298.81 |
You are here: research